{"title":"Intra-lesional Steroid Treatment of Mandibular Central Giant Cell Granuloma","authors":"Mohammed H. Al-Bodbaij","doi":"10.37191/mapsci-2582-3736-4(4)-144","DOIUrl":null,"url":null,"abstract":"Central giant cell granuloma (CGCG) is a non-neoplastic benign lesion. CGCG can be treated by various modalities of which surgery is the most common treatment but have possible variable recurrence rates. Other treatment modalities like calcitonin and intralesional steroid have showed good long-term result in many clinical cases. As CGCG occurs commonly in young adults and children of less than 30 years, noon-surgical treatment is a better and least invasive option. The case of an 18-year-old Saudi female is represented with an aggressive mandible CGCG which has been treated with steroid intralesional injections on a weekly basis for six weeks that has been observed as a good treatment option for CGCG clinically.","PeriodicalId":92922,"journal":{"name":"Journal of dentistry and oral sciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of dentistry and oral sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37191/mapsci-2582-3736-4(4)-144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Central giant cell granuloma (CGCG) is a non-neoplastic benign lesion. CGCG can be treated by various modalities of which surgery is the most common treatment but have possible variable recurrence rates. Other treatment modalities like calcitonin and intralesional steroid have showed good long-term result in many clinical cases. As CGCG occurs commonly in young adults and children of less than 30 years, noon-surgical treatment is a better and least invasive option. The case of an 18-year-old Saudi female is represented with an aggressive mandible CGCG which has been treated with steroid intralesional injections on a weekly basis for six weeks that has been observed as a good treatment option for CGCG clinically.